Human Vaccines and Immunotherapeutics 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 16, 2023 Category: Allergy & Immunology Authors: Somsri WiwanitkitViroj Wiwanitkita Private Academic and Editorial Consultant, Bangkok, Thailandb Center for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, India Source Type: research
Building safety into CAR-T therapy
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 16, 2023 Category: Allergy & Immunology Authors: Daniel T. PetersBarbara SavoldoNatalie S. Grovera Department of Hematology Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, USAb Lineberger Comprehensive Cancer Center, Department of Pediatrics, Hematology Oncology, University o Source Type: research
Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 16, 2023 Category: Allergy & Immunology Authors: Hideaki KatoTakayuki KurosawaKazuo HorikawaYayoi KimuraKei MiyakawaAkihide RyoAtsushi Gotoa Infection Prevention and Control Department, Yokohama City University Hospital, Yokohama, Japanb Clinical Laboratory Department, Yokohama City University Hospital, Source Type: research
A survey of potential acceptance of 9-valent HPV vaccine among Chinese male college students
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 16, 2023 Category: Allergy & Immunology Authors: Shu JiaBo PanDandan HongQingmei ZhangHan JiangYing HongJing Honga Honor College, Wuhan Universtiy, Wuhan, Hubei Province, Chinab School of History, Nanjing University, Nanjing, Jiangsu Province, Chinac Department of Integrative Oncology, The First Affilia Source Type: research
Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC ® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC ® (frozen formulation) in healthy infants
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 16, 2023 Category: Allergy & Immunology Authors: Krishna Kumari PSiddharth Reddy ChitetiVinay K. AileniSudhir BabjiWilliam C. BlackwelderAshok KumarJayant VaghaUma NayakMonjori MitraNarayanaappa DSonali KarSangeeta YadavSwamy NaiduNiranjan MahantshettiVasant KhalatkarSatyajit MohapatraP. K. PurthiPawan Source Type: research
Human vaccines & immunotherapeutics: News October 2023
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 15, 2023 Category: Allergy & Immunology Authors: Ronald EllisAdam Weissa Editor-in-Chief, Jerusalem, Israelb Acquisitions Editor, Taylor & Francis Group Source Type: research
Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 15, 2023 Category: Allergy & Immunology Authors: Raunak ParikhDavid SingerElizabeth Chmielewski-YeeChristophe Dessarta Global Medical Affairs, GSK, Wavre, Belgiumb US Health Outcomes and Epidemiology, GSK, Philadelphia, PA, USAc Epidemiology and Patient Centered Outcomes, GSK, Rockville, MD, USAd Clinic Source Type: research
RSV awareness, risk perception, causes, and terms: Comment
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 15, 2023 Category: Allergy & Immunology Authors: Somsri WiwanitkitViroj Wiwanitkita Private Academic and Editorial Consultant, Bangkok, Thailandb Center for global health research, Saveetha medical college Saveetha Institute of medical and technical sciences, India Source Type: research
Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 15, 2023 Category: Allergy & Immunology Authors: Agnes Mwakingwe-OmariNicolas LecrenierAbdi NaficyDesmond CurranInga Posiunienea Clinical Sciences, GSK, Rockville, MD, USAb Medical Affairs Department, GSK, Wavre, Belgiumc Evidence and Outcome Department, GSK, Wavre, Belgium Source Type: research
End of season 2022/2023 quadrivalent influenza vaccine effectiveness in preventing influenza in primary care in Portugal
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 15, 2023 Category: Allergy & Immunology Authors: Irina KislayaAna Rita TorresLic ínia GomesAryse MeloAusenda MachadoCamila HenriquesNuno VerdascaRaquel GuiomarAna Paula RodriguesNational Influenza Surveillance Networka Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge IP Source Type: research
Views about vaccines and how views changed during the COVID-19 pandemic among a national sample of young gay, bisexual, and other men who have sex with men
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 15, 2023 Category: Allergy & Immunology Authors: Daniel MarshallAnnie-Laurie McReeAmy L. GowerPaul L. Reitera Division of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, OH, USAb Division of General Pediatrics and Adolescent Health, Department of Pedi Source Type: research
Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 15, 2023 Category: Allergy & Immunology Authors: Hazal Cansu ÇulpanSümeyye Nur AydınAbdulkerim UygurUğurcan SayılıErkam Şekerİ̇lker İnanç BalkanRıdvan KaraaliBeyhan BudakYılmaz KeskindemirciNeşe SaltoğluGünay Cana Altındağ District Health Directorate, Çankaya, Ankara, Turkiyeb Departm Source Type: research
Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 15, 2023 Category: Allergy & Immunology Authors: Eliel NhamHye SeongHakjun HyunJin Gu YoonJi Yun NohHee Jin CheongWoo Joo KimEugene KimLeejung ChoiJung-Min LeeJoon Young Songa Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea Source Type: research
Determinants of parental self-reported uptake of influenza vaccination in preschool children during the COVID-19 pandemic
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 15, 2023 Category: Allergy & Immunology Authors: Shujuan QuMinghua YangWei HeHao XieMin ZhouKathryn S. CampyXinyu Taoa Department of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, Chinab School of Business Administration, Hunan University of Technology and Business, Changs Source Type: research
Evolution of global scientific collaboration in mRNA vaccine research: Insights from bibliometric and social network analysis (2010~2023)
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 15, 2023 Category: Allergy & Immunology Authors: Juan ChenLizi PanYan LuTing ZhangDongzi XuShu YanZhaolian OuyangInstitute of Medical Information/Medical Library, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China Source Type: research
